UMIN-CTR History

UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials


Unique ID issued by UMIN UMIN000002456
Receipt No. R000003008
Scientific Title Phase II study of lapatinib plus capecitabin for the HER2 overexpressing metastatic breast cancer patients pretreated with oral-FU agents.
Date of disclosure of the study information 2009/09/07
Last modified on 2017/11/30 18:04:58

No. Disposal Last modified on Item of update
1 Insert 2009/09/06 16:52:12
2 Update 2010/09/06 12:31:50 Recruitment status
3 Update 2011/09/06 22:17:14 Post marketing survey by drug manufacture etc., specified by Japanese law.
4 Update 2011/09/06 22:21:16 Last follow-up date
5 Update 2014/03/06 10:41:49 Last name of lead principal investigator
Last name of lead principal investigator
6 Update 2015/02/16 19:10:38 Recruitment status
Last follow-up date
7 Update 2017/11/30 18:04:58 UMIN ID1

Contact us.